Advertisement
ENDP 外匯新聞
Endo Intl's Par Pharma Recalls Treprostinil Injection For Silicone Particulates
Dublin, Ireland -based Endo International plc announced that its operating company Par Pharmaceutical, Inc. is recalling one lot of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level. The recall, being conducted along with the U.S. Food and Drug Administration, is due to the potential for the presence of silicone particulates in the product solution.
RTTNews
|
436天前
Endo International Narrows FY23 Revenue Outlook Range - Update
While reporting financial results for the second quarter on Tuesday, specialty pharmaceutical company Endo International plc (ENDPQ.PK) narrowed its revenue guidance range for the full-year 2023.
RTTNews
|
654天前
Endo International Says Health Canada Approves XCOPRI To Treat Epilepsy
Specialty pharmaceutical company Endo International plc (ENDPQ.PK) announced Thursday that its operating company Paladin Labs, Inc. (PLB.TO) has received Health Canada's approval of XCOPRI (cenobamate tablets) for adjunctive therapy in the management of partial-onset seizures in adults with epilepsy who are not satisfactorily controlled with conventional therapy.
RTTNews
|
694天前
Endo Int'l Reports Top-line Results From Phase 2 Study Of CCH For Adhesive Capsulitis Of Shoulder
Pharmaceutical company Endo International plc (ENDP) announced Friday top-line results from its Phase 2 study of Collagenase Clostridium Histolyticum (CCH) in participants with adhesive capsulitis (AC) of the shoulder, commonly known as "frozen shoulder."
RTTNews
|
1057天前
